Several social users posted a picture of a woman thrusting a syringe in man’s vein and claimed that the man in the picture is Bharat Biotech’s Vice President, Dr. VK Srinivas, and the first dose of the vaccine was administered on him.
According to a report in Live Mint, Bharat Biotech, an unlisted Indian vaccine maker, has received regulatory approval to start human clinical trials for its experimental shot. The phase 1 trial of Covaxine will begin next week. The company has planned to enroll 375 people in the first phase of clinical trials.
We found that the same image is viral on Twitter and Facebook with a caption, “Dr. V. K.Srinivas, Vice President, Bharat biotech, taking Corona vaccine clinical trial immediately after taking the first dose. He is the first person in India to take vaccine developed by him and his team in Bharat Biotech. Look at the confidence.”
As we began fact-checking the claim, we looked for some media reports backing the claim, but we did not find any authentic information to corroborate.
However, during our research, we came across the statement tweeted by Bharat Biotech. In a statement posted on their Twitter handle, Bharat Biotech said that individual images and messages circulated on social media platforms had not disseminated by Bharat biotech. The image is a routine procedural blood draw for testing all production staff.
We now searched, if Dr.VK Srinivas is the Vice President of the Bharat biotech. During our research, we did not find any results for his name. We found that Dr. V Krishna Mohan is the Executive Director, and T Srinivas is the Chief Financial Officer of the management team of the pharmaceutical.
It is evident from our fact check that social media users circulated a false image claiming that the vice president of Bharat Biotech has undergone the first clinical trial of the coronavirus vaccine.
- Google Search
- Media Reports
- Twitter Search
If you would like us to fact check a claim, give feedback or lodge a complaint, WhatsApp us at 9999499044. You can also visit the Contact Us page and fill the form